[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:best-vitelliform-macular-dystrophy":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":39,"states":40},"Best vitelliform macular dystrophy",5,[7,15,21,27,33],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07185256","Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:18:46.948970Z","2026-05-05T02:43:26.716969Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT05809635","Study of BEST1 Vitelliform Macular Dystrophy",[],"2026-08-26T02:15:28.524219Z","2026-05-13T02:55:06.377944Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT06491615","National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases",[],"2026-08-26T02:17:38.215063Z","2026-05-13T02:55:06.495460Z",{"nct_id":28,"title":29,"phases":30,"status":12,"updated_at":31,"content_modified":32},"NCT02435940","Inherited Retinal Degenerative Disease Registry",[],"2026-08-26T02:16:07.529922Z","2026-05-13T02:55:06.097266Z",{"nct_id":34,"title":35,"phases":36,"status":12,"updated_at":37,"content_modified":38},"NCT01432847","Cell Collection to Study Eye Diseases",[],"2026-08-26T02:17:25.718160Z","2026-05-13T02:55:06.073476Z",[],[41],{"state":42,"count":43,"slug":44},"Maryland",3,"maryland"]